CTNNB1 and colorectal cancer: Aberrant WNT hyperactivation (through stabilizing mutations in ß-catenin (CTNNB1), or in the adenomatous polyposis coli, APC, gene) is particularly common in colorectal cancer (CRC = COAD + READ), and is a major driver of CRC development [44].